Moreover, JQ1 also demonstrated anti-tumor effects via inhibiting the expression of Forkhead box protein M1 (FoxM1) in ovarian cancer (Zhang et al., 2016) and aurora A kinase in triple-negative breast cancer (Sahni et al., 2016), respectively. This evidence concerns the gene FOXM1 and triple-negative breast carcinoma.